(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer
International Journal of Cancer · 2023-11 · 153 (9) · 1579-1591
DOI: 10.1002/ijc.34640 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Journal of Cancer, online erschienen am 05.07.2023. Verfasst von Juan C Rosas und 24 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. Hauptthemen laut MEDLINE: Breast Neoplasms, Sleep Initiation and Maintenance Disorders. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cancer Research UK, Department of Health, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Fatigue is common in breast‐cancer survivors. Our study assessed fatigue longitudinally in breast cancer patients receiving adjuvant radiotherapy (RT) and aimed to identify risk factors associated with long‐term fatigue and underlying fatigue trajectories. Fatigue was measured in a prospective multicenter cohort (REQUITE) using the Multidimensional Fatigue Inventory (MFI‐20) and analyzed using mixed models. Multivariable logistic models identified factors associated with fatigue dimensions at 2 years post‐RT and latent class growth analysis identified individual fatigue trajectories. A total of 1443, 1302, 1203 and 1098 patients completed the MFI‐20 at baseline, end of RT, after 1 and 2 years. Overall, levels of fatigue significantly increased from baseline to end of RT for all fatigue dimensions ( P < .05) and returned to baseline levels after 2 years. A quarter of patients were assigned to latent trajectory high (23.7%) and moderate (24.8%) fatigue classes, while 46.3% and 5.2% to the low and decreasing fatigue classes, respectively. Factors associated with multiple fatigue dimensions at 2 years include age, BMI, global health status, insomnia, pain, dyspnea and depression. Fatigue present at baseline was consistently associated with all five MFI‐20 fatigue dimensions (OR GeneralFatigue = 3.81, P < .001). From latent trajectory analysis, patients with a combination of factors such as pain, insomnia, depression, younger age and endocrine therapy had a particularly high risk of developing early and persistent high fatigue years after treatment. Our results confirmed the multidimensional nature of fatigue and will help clinicians identify breast cancer patients at higher risk of having persistent/late fatigue so that tailored interventions can be delivered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Institute for Medical Information Processing, Biometry and Epidemiology, Ludwig-Maximilians University, Munich, Germany.
- Instituto de Investigación Sanitaria de Santiago de Compostela, Fundación Pública Galega de Medicina Xenómica (FPGMX), Santiago de Compostela, Spain.
- University of Montpellier, INSERM U1194 IRCM, Institut du Cancer Montpellier (ICM), Montpellier, France.
- Patient advocate, Hasselt, Belgium.
- University of Manchester, Manchester, UK.
ORCID-Profile: Juan C Rosas, Miguel E Aguado-Barrera, Sara Gutiérrez-Enríquez
Förderung
- Cancer Research UK
- Department of Health
- Instituto de Salud Carlos III
- Fundación Mutua Madrileña
- Fundación Científica Asociación Española Contra el Cáncer
- Manchester Biomedical Research Centre
Zitieren
APA
Rosas, J. C., Aguado-Barrera, M. E., Azria, D., Briers, E., Elliott, R., Farcy-Jacquet, M. P., Giraldo, A., Gutiérrez-Enríquez, S., Rancati, T., Rattay, T., Reyes, V., Rosenstein, B., De Ruysscher, D., Sperk, E., Stobart, H., Talbot, C., Vega, A., Taboada-Valladares, B., Veldeman, L., …, & REQUITE Consortium (2023). (Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer. International Journal of Cancer, 153(9), 1579-1591. https://doi.org/10.1002/ijc.34640
Vancouver
Rosas JC, Aguado-Barrera ME, Azria D, Briers E, Elliott R, Farcy-Jacquet MP, et al. (Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer. International Journal of Cancer. 2023;153(9):1579-1591. doi:10.1002/ijc.34640
BibTeX
@article{Rosas2023,
author = {Rosas, Juan C and Aguado-Barrera, Miguel E and Azria, David and Briers, Erik and Elliott, Rebecca and Farcy-Jacquet, Marie-Pierre and Giraldo, Alexandra and Gutiérrez-Enríquez, Sara and Rancati, Tiziana and Rattay, Tim and Reyes, Victoria and Rosenstein, Barry and De Ruysscher, Dirk and Sperk, Elena and Stobart, Hilary and Talbot, Christopher and Vega, Ana and Taboada-Valladares, Begoña and Veldeman, Liv and Ward, Tim and Webb, Adam and West, Catharine and Chang-Claude, Jenny and Seibold, Petra and REQUITE Consortium, REQUITE Consortium},
title = {(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer},
journal = {International Journal of Cancer},
year = {2023},
volume = {153},
number = {9},
pages = {1579--1591},
doi = {10.1002/ijc.34640}
}
EUVIMED